ACE gene ID polymorphism in acute coronary syndrome patients
Abstract
Aim. То investigate the association between ID polymorphism of ACE gene and acute coronary syndrome (ACS) development and progression. Material and metliods. This prospective study analyzed hospital and post-hospital (one-year) outcomes in 376 patients with myocardial infarction (MI) or unstable angina (UA), as well as outcome association with ACE gene ID polymorphism. Results. Q-wave IM risk in ACE gene DD genotype patients was 2,1 and 2,5 times higher than in participants with ID or II genotypes, respectively. On the contrary, UA episodes in these patients were significantly less frequent, being registered in 24,8%, 45,8%, and 52,3% of the subjects with DD, ID, and II genotypes, respectively (df=2; p<0,001). Maximal DD genotype prevalence was observed in individuals with creatine kinase and/or its MB-fraction (CK/MB-CK) positive MI, especially in patients under 65. In CK/MB-CK negative MI, as well as in UA, ID and II genotype patients were more prevalent. ACE gene ID and II genotypes were associated with better outcomes after acute myocardial ischemia episodes, but only in those under 75. In the elderly, fatal event risk increased abruptly, being at least twice as high in II genotype individuals than in DD genotype patients. Conclusion. ACE gene DD genotype is associated with Q-wave MI, especially in younger individuals. ID and II genotypes are protective and associated with better outcomes in patients under 75.
About the Authors
R. T. SaygitovRussian Federation
M. G. Glezer
Russian Federation
D. P. Sementsov
Russian Federation
N. A. Malygina
Russian Federation
References
1. Рекомендации ВНОК по лечению острого коронарного синдрома без стойкого подъема сегмента ST на ЭКГ. Кардиология 2004; 4: 9-15.
2. Rigat В., Hubert С., Alhenc-Gelas F., et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86(4): 1343-6.
3. Cambien F., Poirier O., Lecerf L., et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359(6396): 641-4.
4. Малыгина Н.А., Костомарова И.В., Мелентьев И.А. и др. Связь ID полиморфизма гена ангиотензинпревращающего фермента с наследственной предрасположенностью к инфаркту
5. Taniguchi I., Yamazaki T., Wagatsuma К., et al. The DD genotype of angiotensin converting enzyme polymorphism is a risk factor for coronary artery disease and coronary stent restenosis in Japanese patients. Jpn Circ J 2001; 65: 897-900.
6. Buikema H., Pinto Y.M., Rooks G., et al. The deletion polymorphism of the angiotensin-converting enzyme gene is related to phenotypic differences in human arteries. Eur Heart J 1996; 17(5): 787-94.
7. Leatham E, Barley J, Redwood S, et al. Angiotensin71 convert7 ing enzyme (ACE) polymorphism in patients presenting with myocardial infarction or unstable angina. J Hum Hypertens 1994; 8(8): 63578.
8. Samani N.J., O'Toole L., Martin D., et al. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction. JACC 1996; 28(2): 338-44.
9. Andrikopoulos G.K., Richter D.J., Needham E.W., et al. The paradoxical association of common polymorphisms of the renin-angiotensin system genes with risk of myocardial infarction. Eur J Cardiovasc Prev Rehab 2004; 11(6): 477-83.
10. Sayed-Tabatabaei F.A., Schut A.F., Vasquez A.A., et al. Angiotensin converting enzyme gene polymorphism and cardiovascular morbidity and mortality: the Rotterdam Study. J Med Genet 2005; 42(11): 26-30.
11. Tokunaga S., Tsuji H., Nishiue T., et al. Lower mortality in patients with the DD genotype of the angiotensin-converting enzyme gene after acute myocardial infarction. Acta Cardiol 2001; 56(6): 351-5.
12. Глезер M.Г., Сайгитов Р.Т., Семенцов Д.П. и др. Острый коронарный синдром у пожилых: прогноз госпитальной смертности. Клин геронт 2005; 11(1): 13-20.
13. Miller S.A., Dykes D.D., Polesky H.E. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16(3): 1215.
14. Rigat B., Hubert C., Corvol P., Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992; 20: 1433.
15. Dakik H.A., Mahmarian J.J., Verani M.S., et al. Association of angiotensin I-converting enzyme gene polymorphism with myocardial ischemia and patency of infarct-related artery in patients with acute myocardial infarction. JACC 1997; 29(7): 1468-73.
16. Kontos M.C., Fritz L.M., Anderson P., et al. Impact of troponin standard on the prevalence of acute myocardial infarction. Am Heart J 2003; 146:446-52.
17. Поляков С.В., Глезер М.Г., Персиянов-Дубров И.В., и др. Экономическая эффективность введения в клиническую практику современных методов лабораторной диагностики при остром коронарном синдроме. Эконом здравоохр 2002; 2: 18-20.
18. Gardemann A., Fink M., Strieker J., et al. ACE I/D gene polymorphism: presence of the ACE D allele increases the risk of coronary artery disease in younger individuals. Atherosclerosis 1998; 139(1): 153-9.
19. Di Pasquale P., Cannizzaro S., Paterna S. Does angiotensin-converting enzyme gene polymorphism affect blood pressure? Findings after 6 years of follow-up in healthy subjects. Eur J Heart Fail 2004; 6(1): 11-6.
20. Hasdai D., Behar S., Wallentin L., et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J 2002; 23(15): 1190-201.
21. Evans A.E., Poirier O., Kee F., et al. Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. Q J Med 1994; 87(4): 211-4.
22. Frederksen H., Gaist D., Bathum L., et al. Angiotensin I-converting enzyme (ACE) gene polymorphism in relation to physical performance, cognition and survival. A follow-up study of elderly Danish twins. Ann Epidemiol 2003; 13: 57-65.
23. Милосердова О.В., Сломинский П.А., Лимборская С.А. Возрастзависимое изменение частоты аллелей и генотипов инсерпионно-делеционного полиморфизма гена ангиотензинпревращающего фермента. Генетика 2002; 38(1): 87-9.
24. Panza F., Solfrizzi V., D'Introno A., et al. Angiotensin I converting enzyme (ACE) gene polymorphism in centenarians: different allele frequencies between the North and South of Europe. Exp Gerontol 2003; 38(9): 1015-20.
25. Rosengren A., Wallentin L., К. Gitt A., et al. Sex, age, and clinical presentation of acute coronary syndromes. Eur Heart J 2004; 25(8): 663-70.
26. Tsai C.T., FaHin D., Chiang F.T., et al. Angiotensinogen gene haplotype and Hypertension: interaction with ACE gene I allele. Hypertension 2003; 41(1): 9-15.
27. Perola M., Sajantila A., Sarti C., et al. Angiotensin-converting enzyme genotypes in the high-and low-risk area for coronary heart disease in Finland. Genet Epidemiol 1995; 12(4): 391-9.
28. Сайгитов Р.Т., Малыгина Н.А., Бойко Н.В. и др. Полиморфизм ангиотензинпревращающего фермента (АПФ) и эффективность монотерапии ингибиторами АПФ гипертрофии миокарда левого желудочка, развившейся на фоне гипертонической болезни. Альманах «Геронт гериат» 2003; 2: 263-7.
29. Kuznetsova Т., Staessen J.A., Stolarz К., et al. Relationship between left ventricular mass and the ACE D/I polymorphism varies according to sodium intake. J Hypertens 2004; 22(2): 287-95.
Review
For citations:
Saygitov R.T., Glezer M.G., Sementsov D.P., Malygina N.A. ACE gene ID polymorphism in acute coronary syndrome patients. Cardiovascular Therapy and Prevention. 2006;5(8):34-41. (In Russ.)